Medication Safety of Elderly Patients in Hospital and Ambulatory Setting

NCT01578525 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2015-10-30

No results posted yet for this study

Summary

The purpose of this study is to determine whether additional pharmaceutical care for elderly patients (home-cared patients, nursing-home residents) has a positive impact on drug-related readmissions.

Conditions

  • Elderly
  • Pharmaceutical Care
  • Hospital Readmission
  • Health Services for the Aged
  • Medication Safety

Interventions

OTHER

Pharmaceutical Care Service

Checking medication under safety considerations (medication at admission, hospitalization, discharge); recommendations for potentially inappropriate medication (PRISCUS-criteria),

Sponsors & Collaborators

  • Apothekerstiftung Nordrhein, Duesseldorf

    collaborator UNKNOWN
  • Foerderinitiative Pharmazeutische Betreuung e.V., Berlin

    collaborator UNKNOWN
  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Albrecht Eisert, Dr. rer. nat. · University Hospital Aachen, Hospital Pharmacy, Steinbergweg 20, 52074 Aachen, Germany

  • Axel Heidenreich, Prof. Dr. med. · University Hospital Aachen, Department of Urology, Pauwelsstr. 30, 50274 Aachen, Germany

  • Joerg B Schulz, Prof. Dr. med. · University Hospital Aachen, Department of Neurology, Pauwelsstr. 30, 52074 Aachen, Germany

  • Christian Trautwein, Prof. Dr. med. · University Hospital Aachen, Internal Medicine III (Gastroenterology and Metabolic Disorders), Pauwelsstr. 30, 52074 Aachen, Germany

  • Ulrich Jaehde, Prof. Dr. rer. nat. · University of Bonn, Pharmaceutical Institute, Clinical Pharmacy, An der Immenburg 4, 53121 Bonn, Germany

  • Rebekka Heumueller · University Hospital Aachen, Hospital Pharmacy, Steinbergweg 20, 52074 Aachen, Germany

  • Nicolaus Marx, Prof. Dr. med. · University Hospital Aachen,Internal Medicine I (Cardiology, Pneumology, Angiology and Internal Intensive Medicine)

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01578525 on ClinicalTrials.gov